Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine combined with ropivacaine for epidural labor analgesia
ChiCTR1900027847Phase 4Recruiting
- Sponsor
- Qingdao University
- Start
- Dec 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of nalbuphine, ropivacaine and sufentanil in labor pain (2 arms), sponsored by Qingdao University. Primary endpoints: Time to first patient-controlled analgesia request, Onset time of analgesia and 1 more. Started Dec 2019; status: recruiting.
02
Drugs
nalbuphineropivacainesufentanil
03
Conditions
labor pain
Beyond the preview
Go deeper on ChiCTR1900027847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900027847.